Takeda Linking Arms with a “Reborn” Teva, Sees Turning Point in Market as an Opportunity: Japan Biz Chief Iwasaki

Masato Iwasaki, President, Japan Pharma Business Unit, Takeda Takeda Pharmaceutical has moved to establish a joint venture with Teva Pharmaceutical Industries. Teva Takeda Pharma, in which Takeda will have a 49% stake, and its subsidiary Teva Takeda Yakuhin will handle...read more